In the last 12 months, insiders at Cardiff Oncology, Inc. ($CRDF) filed 43 transactions with the SEC: 10 open-market purchases totaling $1,785,240 and 0 sales totaling $0. Net insider sentiment: net buying.
Cardiff Oncology, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- PACE GARY W (Not found) — 4 transactions totaling $1,650,699
- PACE GARY W (Director) — 5 transactions totaling $63,591
- Levine James E. (Chief Financial Officer) — 6 transactions totaling $36,726
- TANNENBAUM RENEE P (Not found) — 1 transaction totaling $34,224
- Mohindru Mani (Interim CEO) — 1 transaction totaling $0
View all SEC Filings for Cardiff Oncology, Inc. (CRDF).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Mohindru Mani | Chief Executive Officer | A | Stock Options | 600000 | $0.00 | 968,766.0000 | 67,360,564 | 162.70% | 0.89% |
| Feb. 13, 2026 | Lindsay Brigitte Ute | Chief Accounting Officer | A | Stock Options | 200000 | $0.00 | 1,025,334.0000 | 67,360,564 | 24.23% | 0.30% |
| Feb. 17, 2026 | Mohindru Mani | Interim CEO | A | Stock Options | 200000 | $0.00 | 368,766.0000 | 67,360,564 | 118.51% | 0.30% |
| July 30, 2025 | PACE GARY W | Not found | P | Common Stock | 15000 | $2.45 | 2,676,352.0000 | 66,524,294 | 0.56% | 0.02% |
| July 30, 2025 | PACE GARY W | Not found | P | Common Stock | 275000 | $2.45 | 2,676,352.0000 | 66,524,294 | 11.45% | 0.41% |
| June 26, 2025 | Markin Rodney S | Director | A | Stock Options | 40565 | $0.00 | 222,865.0000 | 66,524,294 | 22.25% | 0.06% |
| June 26, 2025 | Mohindru Mani | Director | A | Stock Options | 40565 | $0.00 | 168,766.0000 | 66,524,294 | 31.64% | 0.06% |
| June 26, 2025 | TANNENBAUM RENEE P | Director | A | Stock Options | 40565 | $0.00 | 168,766.0000 | 66,524,294 | 31.64% | 0.06% |
| June 26, 2025 | PACE GARY W | Director | A | Stock Options | 40565 | $0.00 | 187,539.0000 | 66,524,294 | 27.60% | 0.06% |
| June 26, 2025 | Armitage James O | Director | A | Stock Options | 40565 | $0.00 | 187,539.0000 | 66,524,294 | 27.60% | 0.06% |
| June 26, 2025 | White Lale | Director | A | Stock Options | 40565 | $0.00 | 158,681.0000 | 66,524,294 | 34.34% | 0.06% |
| March 11, 2025 | Erlander Mark | Chief Executive Officer | A | Stock Options | 758400 | $0.00 | 2,925,098.0000 | 66,524,294 | 35.00% | 1.14% |
| March 11, 2025 | Kabbinavar Fairooz | Chief Medical Officer | A | Stock Options | 150000 | $0.00 | 780,008.0000 | 66,524,294 | 23.81% | 0.23% |
| March 11, 2025 | Levine James E. | Chief Financial Officer | A | Stock Options | 332621 | $0.00 | 1,295,117.0000 | 66,524,294 | 34.56% | 0.50% |
| March 11, 2025 | Smeal Tod | Chief Scientific Officer | A | Stock Options | 332621 | $0.00 | 979,805.0000 | 66,524,294 | 51.40% | 0.50% |
| Dec. 18, 2024 | Levine James E. | Chief Financial Officer | P | Common Stock | 2400 | $5.00 | 67,716.0000 | 0 | 3.67% | 0.00% |
| Dec. 17, 2024 | Levine James E. | Chief Financial Officer | P | Common Stock | 2752 | $5.42 | 65,316.0000 | 0 | 4.40% | 0.00% |
| Dec. 16, 2024 | Levine James E. | Chief Financial Officer | P | Common Stock | 2564 | $3.83 | 62,564.0000 | 0 | 4.27% | 0.00% |
| Dec. 12, 2024 | TANNENBAUM RENEE P | Not found | P | Common Stock | 10000 | $3.42 | 20,000.0000 | 0 | 100.00% | 0.00% |
| Dec. 11, 2024 | PACE GARY W | Not found | P | Common Stock | 350115 | $2.60 | 2,107,252.0000 | 0 | 19.93% | 0.00% |
| Dec. 11, 2024 | PACE GARY W | Not found | P | Common Stock | 11500 | $2.60 | 2,107,252.0000 | 0 | 0.55% | 0.00% |
| June 27, 2024 | PACE GARY W | Director | A | Stock Options | 29700 | $0.00 | 146,974.0000 | 0 | 25.33% | 0.00% |
| June 27, 2024 | White Lale | Director | A | Stock Options | 29700 | $0.00 | 146,974.0000 | 0 | 25.33% | 0.00% |
| June 27, 2024 | TANNENBAUM RENEE P | Director | A | Stock Options | 29700 | $0.00 | 128,201.0000 | 0 | 30.15% | 0.00% |
| June 27, 2024 | Mohindru Mani | Director | A | Stock Options | 29700 | $0.00 | 128,201.0000 | 0 | 30.15% | 0.00% |
| June 27, 2024 | Armitage James O | Director | A | Stock Options | 29700 | $0.00 | 146,974.0000 | 0 | 25.33% | 0.00% |
| June 27, 2024 | Markin Rodney S | Director | A | Stock Options | 29700 | $0.00 | 182,027.0000 | 0 | 19.50% | 0.00% |
| March 7, 2024 | Erlander Mark | Chief Executive Officer | A | Stock Options | 510000 | $0.00 | 2,170,310.0000 | 0 | 30.72% | 0.00% |
| March 7, 2024 | Smeal Tod | Chief Scientific Officer | A | Stock Options | 205008 | $0.00 | 647,184.0000 | 0 | 46.36% | 0.00% |
| March 7, 2024 | Kabbinavar Fairooz | Chief Medical Officer | A | Stock Options | 205008 | $0.00 | 630,008.0000 | 0 | 48.24% | 0.00% |
| March 7, 2024 | Levine James E. | Chief Financial Officer | A | Stock Options | 205008 | $0.00 | 962,496.0000 | 0 | 27.06% | 0.00% |
| Dec. 19, 2023 | PACE GARY W | Director | P | Common Stock | 30000 | $1.37 | 697,761.0000 | 0 | 4.49% | 0.00% |
| Nov. 10, 2023 | PACE GARY W | Director | P | Common Stock | 22950 | $0.98 | 667,761.0000 | 0 | 3.56% | 0.00% |
| June 15, 2023 | PACE GARY W | Director | A | Stock Options | 27700 | $0.00 | 117,274.0000 | 0 | 30.92% | 0.00% |
| June 15, 2023 | Mohindru Mani | Director | A | Stock Options | 27700 | $0.00 | 98,501.0000 | 0 | 39.12% | 0.00% |
| June 15, 2023 | TANNENBAUM RENEE P | Director | A | Stock Options | 27700 | $0.00 | 98,501.0000 | 0 | 39.12% | 0.00% |
| June 15, 2023 | Armitage James O | Director | A | Stock Options | 27700 | $0.00 | 117,274.0000 | 0 | 30.92% | 0.00% |
| June 15, 2023 | White Lale | Director | A | Stock Options | 27700 | $0.00 | 117,274.0000 | 0 | 30.92% | 0.00% |
| June 15, 2023 | Markin Rodney S | Director | A | Stock Options | 27700 | $0.00 | 152,327.0000 | 0 | 22.23% | 0.00% |
| March 15, 2023 | Erlander Mark | Chief Executive Officer | A | Stock Options | 482064 | $0.00 | 1,664,477.0000 | 0 | 40.77% | 0.00% |
| March 15, 2023 | Levine James E. | Chief Financial Officer | A | Stock Options | 197472 | $0.00 | 757,488.0000 | 0 | 35.26% | 0.00% |
| March 15, 2023 | Smeal Tod | Chief Scientific Officer | A | Stock Options | 167088 | $0.00 | 442,176.0000 | 0 | 60.74% | 0.00% |
| March 15, 2023 | Kelemen Vicki | Exec. VP and COO | A | Stock Options | 125520 | $0.00 | 698,304.0000 | 0 | 21.91% | 0.00% |